PHARM - A Phase III, multi-center, open-label study of Methylphenidate Transdermal System (MTS)
Project Description:
A phase III, multi-center, open-label study of Methylphenidate Transdermal System (MTS) in pediatric patients aged 6-13 with Attention-Deficit/Hyperactivity Disorder (ADHD).
Keyword(s):
ADHD, Methylphenidate, pediatrics, MTS
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Specific Groups
Primary Target Audience Geographic Descriptor:
National
COVID-19 Related Data:
N/A